AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 135 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.98 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $598,000 | – | 44,000 | – | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2014 | $773,000 | -25.5% | 24,100 | +7.1% | 0.00% | -40.0% |
| Q1 2014 | $1,038,000 | -28.7% | 22,500 | +9.8% | 0.01% | -28.6% |
| Q4 2013 | $1,455,000 | -20.3% | 20,500 | -3.8% | 0.01% | -12.5% |
| Q3 2013 | $1,826,000 | +40.7% | 21,300 | +3.9% | 0.01% | +33.3% |
| Q2 2013 | $1,298,000 | – | 20,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |